MedCity News August 19, 2025
Nirmal Vemanna

As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry.

Direct patient engagement by life sciences manufacturers is at an all-time high. I am not just referring to direct-to-consumer advertising. Manufacturers are increasingly engaging patients through digital tools, support programs, wearables, etc. Whether it is sending medication reminders or analyzing patients’ behavior in real-time to provide them with helpful resources, these technologies have the potential to improve lives significantly.

However, with such direct patient engagement, there is a new development that not enough life sciences organizations are paying attention to. As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, HIPAA, Pharma, Pharma / Biotech
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat

Share Article